Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PKBO

Peak Bio (PKBO) Stock Price, News & Analysis

Peak Bio logo

About Peak Bio Stock (NASDAQ:PKBO)

Advanced Chart

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.11
52-Week Range
$0.00
$0.26
Volume
66,140 shs
Average Volume
8,940 shs
Market Capitalization
$520.31 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PKBO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Peak Bio and its competitors with MarketBeat's FREE daily newsletter.

PKBO Stock News Headlines

Trump’s $100 Trillion Land Rush Is On
What Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trillions in oil, gas, lithium, and land rights. Whitney Tilson breaks it all down, and shows how everyday Americans can grab a stake. His urgent new briefing explains "The US: IPO"... and how to get in before the looming federal deadline.
Peak Bio Inc (PKBO)
Peak Bio, Inc. (PKBO)
What Peak 65 Means for My Gen X Clients
AKARI THER.ADR/2000 -,01 (CLA.MU)
See More Headlines

PKBO Stock Analysis - Frequently Asked Questions

Peak Bio, Inc. (NASDAQ:PKBO) posted its quarterly earnings data on Tuesday, November, 12th. The company reported $0.06 earnings per share for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Peak Bio investors own include Check-Cap (CHEK), Pulmonx (LUNG), Minerva Neurosciences (NERV), Crescent Biopharma (CBIO), Adicet Bio (ACET), Absci (ABSI) and Aeglea BioTherapeutics (AGLE).

Company Calendar

Last Earnings
11/12/2024
Today
7/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PKBO
CIK
1834645
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.83 million
Net Margins
N/A
Pretax Margin
-4,433.33%
Return on Equity
N/A
Return on Assets
-179.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.07
Quick Ratio
0.06

Sales & Book Value

Annual Sales
$370 thousand
Price / Sales
1.41
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.90) per share
Price / Book
-0.03

Miscellaneous

Outstanding Shares
23,125,000
Free Float
18,523,000
Market Cap
$520.31 thousand
Optionable
Not Optionable
Beta
1.75
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:PKBO) was last updated on 7/28/2025 by MarketBeat.com Staff
From Our Partners